Apyx Medical Corporation - Common Stock (NQ:APYX)

2.520 -0.050 (-1.95%)

Delayed Quote Updated: 10:57 AM EDT, Oct 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Apyx Medical Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 Next >

Recap of Monday's Biotech Catalysts - End of the Day Summary ↗

July 18, 2022

Abbvie (NYSE: ABBV) has submitted a marketing authorization application (MAA) to the European Medicines Agency (EMA) for atogepant for the prophylaxis of migraine in adult patients who have at least...

Via Benzinga

Apyx Medical's Renuvion Scores FDA Approval To Eliminate Sagging Neck ↗

July 18, 2022

Via Benzinga

Apyx Medical Corporation Receives FDA 510(k) Clearance for the Use of Renuvion® to Improve Appearance of Lax (Loose) Skin

July 18, 2022

From Apyx Medical Corporation

Via Business Wire

APYX INVESTOR NEWS: ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Apyx Medical Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - APYX

July 15, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Apyx Medical Posts Encouraging Data From Renuvion Device In Sagging Skin ↗

July 11, 2022

Via Benzinga

Apyx Medical Corporation Announces Results of the U.S. IDE Clinical Study Evaluating the Use of Renuvion to Improve the Appearance of Lax Skin in the Neck and Submental Region

July 08, 2022

From Apyx Medical Corporation

Via Business Wire

ROSEN, LEADING INVESTOR COUNSEL, Encourages Apyx Medical Corporation Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - APYX

July 04, 2022

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Topics Lawsuit

Apyx Medical Corporation to Release Second Quarter of Fiscal Year 2022 Financial Results on August 11, 2022

June 30, 2022

From Apyx Medical Corporation

Via Business Wire

NASDAQ:APYX Investor Alert: Lawsuit Alleges Securities Laws Violations by Apyx Medical Corporation ↗

June 21, 2022

San Diego, CA -- (SBWIRE) -- 06/21/2022 -- An investor, who purchased NASDAQ:APYX shares, filed a lawsuit against Apyx Medical Corporation over alleged Federal Securities Laws violations.

Via SBWire

Apyx Medical Corporation Investor News: Robbins LLP is Investigating Apyx Medical Corporation (APYX) on Behalf of Shareholders

June 17, 2022

From Robbins LLP

Via Business Wire

Kirby McInerney LLP Reminds Investors That a Class Action Lawsuit Has Been Filed on Behalf of APYX Medical Corporation (APYX) Investors and Encourages Investors to Contact the Firm Before August 5, 2022

June 17, 2022

From Kirby McInerney LLP

Via Business Wire

Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Apyx Medical Corporation (APYX)

June 13, 2022

From Law Offices of Howard G. Smith

Via Business Wire

91 Biggest Movers From Friday ↗

June 13, 2022

Gainers RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto.

Via Benzinga

APYX Shareholder News: Robbins LLP Reminds Investors of Class Action Against Apyx Medical Corporation (APYX)

June 10, 2022

From Robbins LLP

Via Business Wire

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Apyx Medical Corporation (APYX)

June 09, 2022

From Glancy Prongay & Murray LLP

Via Business Wire

Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Apyx Medical Corporation (APYX)

June 08, 2022

From Robbins LLP

Via Business Wire

EQUITY ALERT: Rosen Law Firm Encourages Apyx Medical Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – APYX

June 08, 2022

From The Rosen Law Firm, P.A.

Via Business Wire

Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of APYX Medical Corporation (APYX) Investors

June 08, 2022

From Kirby McInerney LLP

Via Business Wire

The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Apyx Medical Corporation (APYX) Investors

June 08, 2022

From The Law Offices of Frank R. Cruz

Via Business Wire

Bronstein, Gewirtz & Grossman, LLC Notifies Apyx Medical Corporation (APYX) Investors of Class Action and Encourages Investors to Contact the Firm

June 08, 2022

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in Apyx Medical Corporation with Losses of $100,000 to Contact the Firm

June 08, 2022

From The Schall Law Firm

Via Business Wire

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Apyx Medical Corporation with Losses of $100,000 to Contact the Firm

June 07, 2022

From The Schall Law Firm

Via Business Wire

APYX CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Apyx Medical Corporation

June 07, 2022

From The Law Offices of Frank R. Cruz

Via Business Wire

APYX ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Apyx Medical Corporation and Encourages Investors to Contact the Firm

June 06, 2022

From Bragar Eagel & Squire, P.C.

Via Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Apyx Medical Corporation (APYX) Investors

June 06, 2022

From Law Offices of Howard G. Smith

Via Business Wire

APYX CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Apyx Medical Corporation

June 06, 2022

From Glancy Prongay & Murray LLP

Via Business Wire

88 Biggest Movers From Yesterday ↗

May 27, 2022

Gainers Creatd, Inc. (NASDAQ: CRTD) shares jumped 58.5% to close at $1.28 on Thursday. Creatd’s board approved a rights offering of up to $40 million for 20 million shares at $2 per unit.

Via Benzinga

Mid-Afternoon Market Update: Dow Surges 575 Points; Apyx Medical Shares Spike Higher ↗

May 26, 2022

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining 575 points on Thursday.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 26, 2022

Via Benzinga

Apyx Medical Stock Gains Following FDA Clearance of Renuvion Dermal Handpiece for Wrinkle Reduction ↗

May 26, 2022

The U.S. Food and Drug Administration (FDA) announced 510(k) clearance (pre-market notification) of Apyx Medical’s (NASDAQ: APYX) Renuvion Dermal Handpiece for specific dermal resurfacing procedures.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.